
DexCom Inc. Stock Underperforms Friday When Compared To Competitors

I'm PortAI, I can summarize articles.
DexCom Inc.'s stock fell 2.87% to $66.96 on Friday, ending an 11-day winning streak. It underperformed compared to competitors like Abbott Laboratories and Insulet Corp. The stock is 28.19% below its 52-week high. Trading volume was higher than the 50-day average. The S&P 500 and Dow Jones also fell on the same day.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

